<DOC>
	<DOCNO>NCT00832871</DOCNO>
	<brief_summary>The purpose study see mifepristone prevents worsen cancer . Mifepristone antiprogesterone agent , drug block female hormone , commonly use termination pregnancy . It approve Food Drug Administration use treatment cancer . It unlicensed United States condition . However , previous work indicate mifepristone may useful due work . It make available use United States compassionate use Feminist Majority Foundation .</brief_summary>
	<brief_title>Compassionate Use Mifepristone Brain/Nervous System Other Cancers</brief_title>
	<detailed_description>This compassionate use mifepristone treatment patient condition could respond antiprogesterone agent , include : - Meningioma . - Breast cancer - Colon Cancer - Endometrial Stromal Sarcoma - Bilateral Chronic Central Serous Retinopathy - Cushing 's Syndrome - Metastatic Adrenocortical Cancer - Ovarian Cancer - Other condition determine attend physician</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>All patient 18 year age old . Patients must sign informed consent . Patients health condition opinion attend physician administration mifepristone benefit may outweigh risk . Pregnant woman nurse mother eligible trial . Patients child bear potential must use adequate contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Mifepristone</keyword>
	<keyword>RU-486</keyword>
	<keyword>Compassionate Use</keyword>
	<keyword>Antiprogesterone</keyword>
</DOC>